| Style | Citing Format |
|---|---|
| MLA | Taymouri S, Mostafavi A, Talabaki H. "Formulation and Evaluation of Taste-Masked Oral Disintegrating Tablet Containing Tolterodine-Loaded Montmorillonite." Research in Pharmaceutical Sciences, vol. 18, no. 5, 2023, pp. 528-540. |
| APA | Taymouri S, Mostafavi A, Talabaki H (2023). Formulation and Evaluation of Taste-Masked Oral Disintegrating Tablet Containing Tolterodine-Loaded Montmorillonite. Research in Pharmaceutical Sciences, 18(5), 528-540. |
| Chicago | Taymouri S, Mostafavi A, Talabaki H. "Formulation and Evaluation of Taste-Masked Oral Disintegrating Tablet Containing Tolterodine-Loaded Montmorillonite." Research in Pharmaceutical Sciences 18, no. 5 (2023): 528-540. |
| Harvard | Taymouri S, Mostafavi A, Talabaki H (2023) 'Formulation and Evaluation of Taste-Masked Oral Disintegrating Tablet Containing Tolterodine-Loaded Montmorillonite', Research in Pharmaceutical Sciences, 18(5), pp. 528-540. |
| Vancouver | Taymouri S, Mostafavi A, Talabaki H. Formulation and Evaluation of Taste-Masked Oral Disintegrating Tablet Containing Tolterodine-Loaded Montmorillonite. Research in Pharmaceutical Sciences. 2023;18(5):528-540. |
| BibTex | @article{ author = {Taymouri S and Mostafavi A and Talabaki H}, title = {Formulation and Evaluation of Taste-Masked Oral Disintegrating Tablet Containing Tolterodine-Loaded Montmorillonite}, journal = {Research in Pharmaceutical Sciences}, volume = {18}, number = {5}, pages = {528-540}, year = {2023} } |
| RIS | TY - JOUR AU - Taymouri S AU - Mostafavi A AU - Talabaki H TI - Formulation and Evaluation of Taste-Masked Oral Disintegrating Tablet Containing Tolterodine-Loaded Montmorillonite JO - Research in Pharmaceutical Sciences VL - 18 IS - 5 SP - 528 EP - 540 PY - 2023 ER - |